US 10927372
Compositions and methods for modulating apolipoprotein C-III expression
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 10927372 (Compositions and methods for modulating apolipoprotein C-III expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/549, A61K47/59